Folic Acid: Uses, Dosage & Side Effects
Vitamin B9 — Essential for blood cell formation and fetal development
Quick Facts About Folic Acid
Key Takeaways About Folic Acid
- Essential for pregnancy: Folic acid supplementation before conception and during early pregnancy reduces the risk of neural tube defects (such as spina bifida) by up to 70%, according to WHO and major international health guidelines
- Treats folate deficiency anemia: Folic acid is required for normal red blood cell production. Deficiency leads to megaloblastic anemia with symptoms including fatigue, weakness, and shortness of breath
- Critical warning — B12 masking: Do not take folic acid without medical supervision, as it can mask vitamin B12 deficiency by correcting the anemia while allowing potentially irreversible neurological damage to progress
- Drug interactions with antiepileptics: Folic acid has a bidirectional interaction with phenytoin, carbamazepine, and phenobarbital — these drugs reduce folate levels, while folic acid can reduce their effectiveness
- Very well tolerated: Folic acid has an excellent safety profile at recommended doses. Allergic reactions are extremely rare. Excess folic acid is excreted in urine as it is water-soluble
What Is Folic Acid and What Is It Used For?
Folic acid is the synthetic (manufactured) form of folate, a water-soluble B vitamin (vitamin B9) that is essential for DNA synthesis, cell division, and normal blood cell formation. It is prescribed to treat and prevent folic acid deficiency, which can cause megaloblastic anemia, and is recommended for all women planning pregnancy to prevent neural tube defects in the developing fetus.
Folic acid belongs to the group of B vitamins and is the most stable and bioavailable form of folate. While folate occurs naturally in foods such as dark leafy greens, legumes, and liver, folic acid is the synthetic form used in supplements and fortified foods. Once ingested, folic acid is converted in the body to its active metabolites — dihydrofolate and tetrahydrofolate — which serve as essential coenzymes for one-carbon transfer reactions in numerous metabolic pathways.
The body cannot synthesize folate on its own, making it an essential nutrient that must be obtained through diet or supplementation. In most cases, a balanced diet provides adequate folate. However, certain conditions increase folate requirements or impair its absorption, necessitating supplementation with folic acid. These include pregnancy and breastfeeding, chronic hemolytic anemias (such as sickle cell disease or thalassemia), malabsorption syndromes (such as celiac disease or inflammatory bowel disease), and treatment with certain medications that interfere with folate metabolism.
Folic acid was first identified in the 1940s when it was isolated from spinach leaves (the name derives from the Latin word folium, meaning leaf). It was recognized as essential for human health, and its critical role in preventing birth defects was established through landmark clinical trials in the 1990s. Today, folic acid is included on the World Health Organization’s (WHO) List of Essential Medicines, reflecting its fundamental importance in global health.
Common Indications
Folic acid is prescribed for a range of clinical indications. The specific use and dosage depend on the underlying condition and the patient’s individual needs:
- Prevention of neural tube defects (NTDs): The most well-established preventive use of folic acid. Women who are planning to become pregnant or who could become pregnant are advised to take folic acid starting at least one month before conception and continuing through the first 12 weeks of pregnancy. This supplementation has been shown to reduce the risk of NTDs (including spina bifida, anencephaly, and encephalocele) by 50–70%.
- Treatment of folate deficiency anemia: Megaloblastic anemia resulting from insufficient folate intake, malabsorption, or increased demand. Folic acid rapidly corrects the hematological abnormalities and replenishes body stores.
- Prevention of folate deficiency: In conditions associated with chronic folate loss or increased requirements, such as chronic hemolytic anemias (sickle cell disease, thalassemia major, hereditary spherocytosis), renal dialysis, alcoholism, and chronic liver disease.
- Drug-induced folate deficiency: Certain medications impair folate metabolism or absorption. These include methotrexate (a folate antagonist used in cancer and autoimmune diseases), sulfasalazine, trimethoprim, phenytoin, carbamazepine, and phenobarbital. Folic acid supplementation may be prescribed alongside these medications.
- Pregnancy and breastfeeding supplementation: Pregnancy increases folate requirements significantly due to rapid cell growth and division in the developing fetus. Breastfeeding also increases folate demands. Supplementation ensures adequate levels for both mother and child.
- Malabsorption conditions: Conditions such as celiac disease, Crohn’s disease, tropical sprue, and short bowel syndrome can impair folate absorption from food, requiring supplementation.
After oral ingestion, folic acid is absorbed primarily in the proximal jejunum of the small intestine. It is then reduced to dihydrofolate (DHF) by the enzyme dihydrofolate reductase (DHFR), and subsequently to tetrahydrofolate (THF), the biologically active form. THF and its derivatives serve as coenzymes in the transfer of one-carbon units, which are essential for the synthesis of purines and thymidylate — the building blocks of DNA. This makes folate indispensable for cell division and growth. Additionally, folate plays a key role in the remethylation of homocysteine to methionine, an important amino acid cycle. Deficiency in folate leads to impaired DNA synthesis, particularly affecting rapidly dividing cells such as bone marrow precursors (causing megaloblastic anemia) and embryonic neural tissue (causing neural tube defects).
What Should You Know Before Taking Folic Acid?
Before taking folic acid, it is essential to be aware that high doses can mask vitamin B12 deficiency (pernicious anemia) by correcting the blood abnormalities while allowing irreversible neurological damage to progress. Folic acid should be used with caution in patients with certain cancers and should only be taken under medical supervision. Always inform your doctor about all medications you are taking.
While folic acid is generally considered very safe at recommended doses, there are important medical considerations that should be evaluated before starting treatment. Understanding these precautions helps ensure that folic acid is used safely and effectively.
Contraindications
You should not take folic acid if:
- Allergy to folic acid or its excipients: If you have a known hypersensitivity to folic acid or any of the inactive ingredients in the tablet formulation, you should not take this medication. Allergic reactions to folic acid are extremely rare but have been reported.
- Undiagnosed megaloblastic anemia: Folic acid must not be used to treat megaloblastic anemia until the underlying cause has been determined. If the anemia is due to vitamin B12 deficiency, administering folic acid alone can correct the blood picture while allowing the neurological damage from B12 deficiency to continue unchecked and potentially become irreversible.
Warnings and Precautions
Speak with your healthcare provider before taking folic acid if any of the following situations apply to you:
Do not take folic acid without a doctor’s prescription. Folic acid can mask the symptoms of vitamin B12 deficiency (pernicious anemia) by correcting the megaloblastic anemia, while the underlying B12 deficiency continues to cause potentially irreversible neurological damage including subacute combined degeneration of the spinal cord, peripheral neuropathy, and cognitive impairment. Your doctor should check your vitamin B12 levels before prescribing high-dose folic acid therapy.
Certain cancers and tumor diseases: Folic acid should be used with caution in patients with cancer or a history of cancer. Because folic acid supports DNA synthesis and cell division, there is a theoretical concern that supplementation could promote the growth of pre-existing malignant cells. Consult your oncologist before starting folic acid if you are being treated for any malignancy. This is particularly relevant for colorectal adenomas and other folate-sensitive tumors.
Epilepsy: Patients taking antiepileptic drugs (such as phenytoin, carbamazepine, or phenobarbital) should use folic acid only under careful medical supervision. Folic acid supplementation can reduce the blood levels of these medications, potentially increasing the frequency of seizures. Conversely, these medications can deplete folate levels. Careful monitoring and dose adjustment may be required for both the antiepileptic drug and folic acid.
Hereditary conditions: In the rare inherited condition dihydrofolate reductase (DHFR) deficiency, folic acid cannot be converted to its active form and will not be effective. In such cases, folinic acid (leucovorin) may be used as an alternative.
Pregnancy and Breastfeeding
Folic acid is not only safe during pregnancy and breastfeeding — it is strongly recommended. This is one of the few medications where the evidence for benefit during pregnancy is exceptionally robust and well established.
Pregnancy: Folic acid supplementation before conception and during the first trimester is one of the most effective preventive measures in maternal and fetal medicine. The WHO recommends that all pregnant women take daily folic acid supplementation. Standard recommendations include:
- Standard risk: 400 micrograms (0.4 mg) daily, starting at least one month before planned conception and continuing through the first 12 weeks of pregnancy
- High risk: 4–5 mg daily for women who have had a previous pregnancy affected by a neural tube defect, who have diabetes, who are taking antiepileptic drugs, or who are obese (BMI >30). Treatment should begin at least 3 months before conception and continue through the first 12 weeks of pregnancy
No adverse effects on the fetus have been demonstrated at recommended therapeutic doses. Folic acid has been used extensively in pregnancy for decades with an excellent safety record.
Breastfeeding: Folic acid passes into breast milk, but this is not expected to harm the nursing infant. In fact, adequate folate intake by the mother ensures that the breast milk provides sufficient folate for the growing baby. Breastfeeding increases the mother’s folate requirements, and supplementation may be recommended.
Driving and Operating Machinery
Folic acid does not affect the ability to drive or operate machinery. There are no known effects on alertness, reaction time, or cognitive function at any recommended dose.
How Does Folic Acid Interact with Other Drugs?
Folic acid interacts with several important medication classes, most notably antiepileptic drugs, methotrexate, and certain antibiotics. The interactions are often bidirectional: some drugs reduce folate levels in the body, while folic acid can reduce the effectiveness of certain drugs. Always inform your doctor about all medications you are taking before starting folic acid.
Drug interactions with folic acid occur through several mechanisms. Some medications impair folate absorption, increase its excretion, or inhibit its metabolic conversion to active forms. Conversely, folic acid can alter the pharmacokinetics of certain drugs, particularly those that depend on folate metabolism. Understanding these interactions is crucial for safe and effective treatment.
Major Interactions
The following interactions are considered clinically significant and may require dose adjustments, alternative therapies, or close monitoring:
| Drug | Interaction | Clinical Significance |
|---|---|---|
| Phenytoin | Bidirectional: phenytoin reduces folate levels; folic acid may reduce phenytoin levels and increase seizure risk | Monitor phenytoin levels closely; adjust doses as needed |
| Carbamazepine | Bidirectional: carbamazepine depletes folate; folic acid may reduce carbamazepine effectiveness | Monitor drug levels and seizure control |
| Phenobarbital | Similar bidirectional interaction as with phenytoin; mutual reduction of levels | Monitor anticonvulsant levels; adjust doses |
| Methotrexate | Methotrexate is a folate antagonist that works by inhibiting dihydrofolate reductase; folic acid may reduce methotrexate efficacy in cancer treatment | For cancer: do not supplement without oncologist approval. For autoimmune diseases: folic acid often co-prescribed to reduce side effects |
| Sulfasalazine | Inhibits folate absorption in the intestine and competitively inhibits folate-dependent enzymes | Folate supplementation often recommended during therapy |
Other Notable Interactions
The following interactions are worth noting, though they may be less critical. Your healthcare provider should still be informed if you are taking any of these medications:
| Drug | Effect | Action Required |
|---|---|---|
| Cholestyramine | Reduces folic acid absorption by binding it in the gut | Take folic acid 1 hour before or 4–6 hours after cholestyramine |
| Trimethoprim | Inhibits dihydrofolate reductase; may cause folate depletion with prolonged use | Monitor folate levels during long-term antibiotic use |
| Pyrimethamine | Potent dihydrofolate reductase inhibitor; can cause severe folate depletion | Folinic acid (not folic acid) often given concurrently |
| Oral contraceptives | May slightly reduce serum folate concentrations | Consider folate supplementation, especially if planning pregnancy |
| Antidiabetic drugs (metformin) | Long-term metformin use may reduce folate and B12 absorption | Periodic monitoring of folate and B12 levels |
| Certain antibiotics (tetracyclines, chloramphenicol) | May interfere with the hematological response to folic acid by suppressing bone marrow activity | Be aware of potentially blunted response to folic acid therapy |
Folinic acid (leucovorin, calcium folinate) is a reduced form of folic acid that does not require conversion by dihydrofolate reductase. It is used specifically to rescue patients from methotrexate toxicity (“leucovorin rescue”) and in situations where dihydrofolate reductase inhibitors are used. Folic acid and folinic acid are not interchangeable — always use the form specifically prescribed by your doctor.
What Is the Correct Dosage of Folic Acid?
The standard preventive dose for adults is 1 tablet (1 mg) daily. For established folate deficiency, the dose is typically 2 tablets (2 mg) taken 2–3 times daily for two weeks, then reduced to 1 mg daily for maintenance. For prevention of neural tube defects in pregnancy, 0.4–5 mg daily is recommended depending on individual risk factors. Your doctor will determine the appropriate dose for your specific situation.
Folic acid dosing depends on the specific indication, the severity of deficiency, and the patient’s individual clinical circumstances. The following guidelines represent standard dosing recommendations from international prescribing information. Always follow the dose prescribed by your healthcare provider, as they may adjust the regimen based on your blood test results and clinical response.
Adults
| Indication | Dose | Duration |
|---|---|---|
| Prevention of folate deficiency | 1 mg once daily | As directed by doctor |
| Established folate deficiency (treatment) | 2 mg (2 tablets) 2–3 times daily | 2 weeks or until blood values normalize; then 1 mg daily maintenance |
| Pregnancy — standard risk (NTD prevention) | 0.4 mg daily | From 1 month before conception through first 12 weeks |
| Pregnancy — high risk (previous NTD, diabetes, antiepileptic drugs, BMI >30) | 4–5 mg daily | From 3 months before conception through first 12 weeks |
| Chronic hemolytic anemia (sickle cell, thalassemia) | 5 mg once daily | Long-term as directed by hematologist |
| Drug-induced deficiency (with methotrexate for autoimmune diseases) | 5 mg once weekly (not on same day as methotrexate) | Throughout methotrexate treatment |
| Renal dialysis patients | 5 mg daily or after each dialysis session | Long-term under nephrologist supervision |
Children
Folic acid is used in pediatric patients for the treatment and prevention of folate deficiency. Dosing in children depends on age, weight, and the underlying condition:
Pediatric Dosing
- Infants and young children (up to 1 year): 0.5 mg daily for folate deficiency (under specialist supervision)
- Children (1–18 years): 1 mg daily for folate deficiency
- Children with chronic hemolytic anemias: 1–5 mg daily as directed by a pediatric hematologist
Pediatric doses should always be determined by a physician. The tablet can be split in half along the score line to facilitate dosing.
Elderly Patients
No specific dose adjustment is required for elderly patients based on age alone. However, older adults are at increased risk of folate deficiency due to reduced dietary intake, decreased intestinal absorption, polypharmacy (multiple medications that may interfere with folate metabolism), and concurrent chronic diseases. Healthcare providers should consider checking folate and vitamin B12 levels before starting supplementation in elderly patients, as the risk of undiagnosed B12 deficiency is higher in this population.
How to Take Folic Acid
Folic acid tablets are easy to take and do not require special administration techniques:
- With or without food: Folic acid can be taken at any time of day, with or without food. Food does not significantly affect absorption of the synthetic form.
- With water: Swallow the tablet with a glass of water.
- Consistency: Try to take your dose at the same time each day to help establish a routine and ensure consistent levels.
- Tablet splitting: The 1 mg tablet is scored and can be divided into two equal halves if a lower dose is needed.
Missed Dose
If you forget to take a dose, simply take the next dose at the correct time. Do not take a double dose to make up for a missed tablet. Because folic acid builds up in the body over time, missing a single dose is unlikely to cause any significant clinical effect.
Overdose
Folic acid has a very wide therapeutic margin, and overdose with serious consequences is extremely unlikely. Because folic acid is water-soluble, excess amounts are excreted by the kidneys in the urine. There is no specific antidote. In the unlikely event that a large quantity is ingested — for example, if a child accidentally takes multiple tablets — contact your local poison control center or healthcare provider for advice as a precaution. Extremely high doses taken over a prolonged period may theoretically cause gastrointestinal disturbances, sleep disturbances, or irritability, but clinically significant toxicity from folic acid alone is extremely rare.
What Are the Side Effects of Folic Acid?
Folic acid is very well tolerated and side effects are uncommon. The most notable concern is not a direct side effect but rather the risk of masking vitamin B12 deficiency. Rare adverse effects include allergic reactions (skin rash, itching, hives) and, extremely rarely, anaphylaxis. If you experience signs of a serious allergic reaction, seek immediate medical attention.
Folic acid has an excellent safety profile at recommended therapeutic doses. Side effects are rare and typically mild. Because folic acid is a water-soluble vitamin, excess amounts are readily excreted by the kidneys, which limits the risk of accumulation and toxicity. However, as with all medications, monitoring for adverse effects is advisable.
- Sudden wheezing, swelling of the face, lips, tongue, or throat
- Severe skin rash or hives spreading across the body
- Difficulty breathing or swallowing
- Drop in blood pressure, dizziness, or feeling faint (signs of anaphylaxis)
These symptoms suggest a serious allergic reaction (anaphylaxis), which has been reported in an unknown number of folic acid users. While extremely rare, it requires immediate emergency treatment.
Rare Side Effects
- Itching (pruritus)
- Skin rash (erythema, maculopapular rash)
- Hives (urticaria)
Very Rare Side Effects
- Serious allergic reaction (anaphylaxis) with skin rash, swelling, and blood pressure drop
- Bronchospasm (sudden shortness of breath)
Considerations with High Doses or Long-Term Use
While folic acid itself has minimal direct toxicity, there are several important considerations associated with its use that healthcare providers and patients should be aware of:
- Masking of vitamin B12 deficiency: This is the most clinically significant risk associated with folic acid use. High doses of folic acid can correct the megaloblastic anemia caused by B12 deficiency, normalizing the blood picture and removing the key diagnostic clue. Meanwhile, the neurological damage from B12 deficiency — including peripheral neuropathy, subacute combined degeneration of the spinal cord, and cognitive decline — continues to progress and may become irreversible. This is why B12 levels should always be assessed before starting high-dose folic acid therapy.
- Potential cancer concerns (high-dose, long-term): Some observational studies have raised concerns that very high doses of folic acid taken over long periods may promote the progression of pre-existing cancerous or precancerous lesions, particularly colorectal adenomas. However, the evidence remains inconclusive and debated. At recommended therapeutic doses, folic acid is not considered carcinogenic.
- Gastrointestinal effects (high doses): Very high doses of folic acid (typically well above therapeutic levels) may occasionally cause mild gastrointestinal symptoms including nausea, bloating, flatulence, or altered taste. These are usually transient and resolve with dose reduction.
- Unmetabolized folic acid: At doses above approximately 200 micrograms, synthetic folic acid may appear in the bloodstream in its unmetabolized form. The clinical significance of unmetabolized folic acid is still being researched, though current evidence does not suggest harm at standard therapeutic doses.
If you experience any side effects, including those not listed above, report them to your healthcare provider. You can also report side effects directly to your national pharmacovigilance authority (e.g., the FDA MedWatch program in the United States, the Yellow Card Scheme in the United Kingdom, or the EMA in the European Union). Reporting helps ensure the ongoing safety monitoring of medications.
How Should You Store Folic Acid?
Store folic acid at room temperature in its original packaging. Protect from light and moisture. Keep out of reach of children and do not use after the expiration date printed on the package.
Proper storage ensures that folic acid tablets remain effective throughout their shelf life. Folic acid is a relatively stable compound but can degrade when exposed to certain environmental conditions.
- Temperature: Store at room temperature. No special temperature requirements are needed under normal household conditions.
- Light protection: Folic acid is sensitive to light, particularly ultraviolet light. Keep tablets in their original blister pack or container. Avoid transferring to clear pill organizers for extended periods.
- Moisture protection: Keep the container tightly closed. Avoid storing in humid environments such as bathrooms.
- Children: Keep out of sight and reach of children.
- Expiration: Do not use folic acid after the expiration date printed on the packaging. The expiration date refers to the last day of the indicated month.
- Disposal: Do not dispose of medications via wastewater or household waste. Return unused or expired medications to a pharmacy for proper disposal to help protect the environment.
What Does Folic Acid Contain?
Each tablet contains 1 mg of folic acid (pteroylglutamic acid) as the active ingredient. Inactive ingredients include microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium, colloidal anhydrous silicon dioxide, and stearic acid. Folic acid is also available as 5 mg tablets.
Understanding the composition of your medication can help identify potential allergens or intolerances. The inactive ingredients (excipients) may vary between manufacturers and brands.
Active Ingredient
The active substance is folic acid (pteroylglutamic acid), a synthetic form of folate (vitamin B9). Each tablet contains 1 mg of folic acid. Folic acid is a yellow to yellowish-orange crystalline powder that is very slightly soluble in water.
Common Excipients
While exact formulations vary by manufacturer, common inactive ingredients in folic acid tablets include:
- Hydroxypropyl cellulose (E 463) — binder
- Croscarmellose sodium — disintegrant
- Microcrystalline cellulose (E 460) — filler and binder
- Colloidal anhydrous silicon dioxide — glidant
- Stearic acid — lubricant
Tablet Appearance
Folic acid 1 mg tablets are typically yellowish to orange, round, convex tablets approximately 7 mm in diameter, with “1” engraved on one side and a score line on the other. The tablet can be divided into two equal halves along the score line. The 5 mg tablets are also available for higher-dose indications.
Available Pack Sizes
Folic acid is available in various pack sizes depending on the manufacturer, commonly including:
- Blister packs: 90 and 100 tablets
- Plastic containers: 100 and 1,000 tablets (hospital/dispensary packs)
Not all pack sizes may be marketed in all countries.
Frequently Asked Questions About Folic Acid
Medical References
All medical information in this article is based on peer-reviewed research, international clinical guidelines, and official drug regulatory documentation. Evidence level: 1A (systematic reviews and meta-analyses of randomized controlled trials).
- World Health Organization (WHO) (2023). “Model List of Essential Medicines — 23rd list.” WHO Essential Medicines Folic acid listed as an essential medicine for anemia and pregnancy supplementation.
- European Medicines Agency (EMA). “Folic Acid — Summary of Product Characteristics.” EMA Official European regulatory documentation for folic acid products.
- U.S. Food and Drug Administration (FDA). “Folic Acid — Prescribing Information and Safety Data.” FDA FDA-approved labeling and safety information for folic acid.
- British National Formulary (BNF). “Folic acid: Indications, dose, contraindications, side effects, interactions.” BNF / NICE Comprehensive UK drug monograph including dosing and interaction data.
- De-Regil LM, et al. (2015). “Effects and safety of periconceptional oral folate supplementation for preventing birth defects.” Cochrane Database of Systematic Reviews. Issue 12, CD007950. doi:10.1002/14651858.CD007950.pub3 Cochrane systematic review confirming folic acid reduces neural tube defects by 69%.
- WHO (2012). “Guideline: Daily iron and folic acid supplementation in pregnant women.” WHO Guideline WHO recommendation for folic acid supplementation during pregnancy.
- MRC Vitamin Study Research Group (1991). “Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.” The Lancet. 338(8760):131–137. doi:10.1016/0140-6736(91)90133-A Landmark randomized controlled trial that established folic acid for NTD prevention.
Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.
iMedic Medical Editorial Team
Specialists in hematology, pharmacology, and clinical medicine
Our Editorial Team
iMedic's medical content is produced by a team of licensed specialist physicians and medical experts with solid academic backgrounds and clinical experience. Our editorial team includes:
Hematology Specialists
Licensed physicians specializing in hematology and blood disorders, with documented experience in anemia diagnostics and vitamin deficiency management.
Clinical Pharmacologists
Experts in clinical pharmacology with extensive knowledge of drug interactions, pharmacokinetics, and evidence-based prescribing.
Researchers
Academic researchers with published peer-reviewed articles on folate metabolism, neural tube defect prevention, and prenatal nutrition.
Medical Review
Independent review panel that verifies all content against international medical guidelines and current research.
Qualifications and Credentials
- Licensed specialist physicians with international specialist competence
- Documented research background with publications in peer-reviewed journals
- Continuous education according to WHO, EMA, and international medical guidelines
- Follows the GRADE framework for evidence-based medicine
- No conflicts of interest or pharmaceutical industry funding
Transparency: Our team works according to strict editorial standards and follows international guidelines for medical information. All content undergoes multiple peer reviews before publication.
iMedic Editorial Standards
Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
Fact-Checking
All medical claims are verified against peer-reviewed sources and international guidelines.
Update Frequency
Content is reviewed and updated at least every 12 months or when new research emerges.
Corrections Policy
Any errors are corrected immediately with transparent changelog.
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in hematology, pharmacology, obstetrics, and clinical research.